Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
A

Aker Biomarine ASA
OSE:AKBM

Watchlist Manager
Aker Biomarine ASA
OSE:AKBM
Watchlist
Price: 133.4 NOK 2.93% Market Closed
Market Cap: kr11.7B
Write Note Create Alert Ask AI

Wall St Price Targets

AKBM Price Targets Summary
Aker Biomarine ASA

Wall Street analysts forecast AKBM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AKBM is 122.4 NOK with a low forecast of 116.15 NOK and a high forecast of 131.25 NOK.

AKBM Lowest Forecast
Wall Street Target
kr116.15
-13% Downside
AKBM Average Forecast
Wall Street Target
kr122.4
-8% Downside
AKBM Highest Forecast
Wall Street Target
kr131.25
-2% Downside
Lowest Forecast
Price Target
116.15 NOK
13% Downside
Average Forecast
Price Target
122.4 NOK
8% Downside
Highest Forecast
Price Target
131.25 NOK
2% Downside
Aker Biomarine ASA Competitors:
Price Targets

Revenue
Forecast

7% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
7% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 11%.

What are analyst estimates?

Gross Profit
Forecast

0% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
0% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 15%.

What are analyst estimates?

Operating Income
Forecast

-2% / Year
Past Growth
70% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
-2% / Year
Past Growth
70% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Over the last 9 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 3 years is 70%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
28%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
28%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
35%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
35%
Average Beat

What are analyst estimates?

Continue AKBM Research

Summary
AKBM intrinsic value, competitors valuation, and company profile.
DCF Valuation
AKBM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AKBM stock valuation using valuation multiples.
Wall St Estimates
AKBM price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AKBM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Aker Biomarine ASA listings:
F • EUR
1PG
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AKBM's stock price target?
Price Target
122.4 NOK

According to Wall Street analysts, the average 1-year price target for AKBM is 122.4 NOK with a low forecast of 116.15 NOK and a high forecast of 131.25 NOK.

What is the Revenue forecast for Aker Biomarine ASA?
Projected CAGR
11%

Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 11%.

What is the Gross Profit forecast for Aker Biomarine ASA?
Projected CAGR
15%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 15%.

What is the Operating Income forecast for Aker Biomarine ASA?
Projected CAGR
70%

Over the last 9 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 3 years is 70%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.